Stefan Ewert, Ph.D. joined Novartis in 2004 and holds the position of a Senior Investigator within the NIBR Biologics Center. He is responsible for antibody phage display selections done in Basel. Before joining Novartis he was instrumental in developing ESBATech’s scFv-based key technology. During his Ph.D. thesis in the group of Andreas Plückthun at the University of Zürich, Switzerland he published several papers on antibody stability and engineering.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October
To sponsor or exhibit contact:
Derek Cavanagh
+44 (0)207 092 1297
derek.cavanagh@terrapinn.com
To speak:
Joan Shutt
+44 (0)207 092 1134
joan.shutt@terrapinn.com